Lung cancer: First-in-man phase I trial with lorlatinib

被引：1
|
作者：
Romero D.
机构：
来源：
Nature Reviews Clinical Oncology | 2018年 / 15卷 / 1期
关键词：
D O I：
10.1038/nrclinonc.2017.201
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [41] MOVING LENTIVIRAL-BASED GENE THERAPY INTO A FIRST-IN-MAN CF TRIAL
    Griesenbach, U.
    Alton, E.
    Beekman, J.
    Boyd, A.
    Chan, M.
    Davies, J. C.
    Davies, L.
    Davidson, H.
    Dekkers, F.
    Gea-Sorli, S.
    Gill, D.
    Hasegawa, M.
    Higgins, T.
    Hyndman, L.
    McLachlan, G.
    Inoue, M.
    Hyde, S. C.
    Moran, C.
    Meng, C.
    Paul-Smith, M.
    Pringle, I
    Pytel, K.
    Rodriguez-Martinez, A.
    Stevenson, B.
    Tsugumine, S.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 283 - 283
  • [42] Four-Year Clinical Outcomes from the RESOLUTE First-In-Man Trial
    Meredith, Ian T.
    Worthley, Stephen. G.
    Walters, Darren. L.
    Whitbourn, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B55 - B55
  • [43] Minimising risk in first-in-man trials
    Hemelaar, Joris
    LANCET, 2007, 369 (9572): : 1496 - 1497
  • [44] First-in-man study of HCV vaccine
    Nature Reviews Gastroenterology & Hepatology, 2015, 12 (1) : 5 - 5
  • [45] Statistical issues in first-in-man studies
    Senn, Stephen
    Amin, Dipti
    Bailey, Rosemary A.
    Bird, Sheila M.
    Bogacka, Barbara
    Colman, Peter
    Garrett, Andrew
    Grieve, Andrew
    Lachmann, Peter
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2007, 170 : 517 - 579
  • [46] First-in-man and first-of-class-in-man clinical trials in oncology
    Mross, K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (01) : 68 - 70
  • [47] FIRST-IN-MAN AND FIRST-IN-CLASS TAU VACCINE
    Novak, Michal
    NEUROBIOLOGY OF AGING, 2014, 35 : S18 - S18
  • [48] Phase I trial of weekly paclitaxel in advanced lung cancer
    Akerley, W
    Glantz, M
    Choy, H
    Rege, V
    Sambandam, S
    Joseph, P
    Yee, L
    Rodrigues, B
    Wingate, P
    Leone, L
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 153 - 158
  • [49] Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies
    Stathis, A.
    Quesnel, B.
    Amorim, S.
    Thieblemont, C.
    Zucca, E.
    Raffoux, E.
    Dombret, H.
    Peng, Y.
    Palumbo, A.
    Vey, N.
    Thomas, X.
    Michallet, M.
    Gomez-Roca, C.
    Recher, C.
    Karlin, L.
    Yee, K.
    Rezai, K.
    Preudhomme, C.
    Facon, T.
    Herait, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 196 - 196
  • [50] First-in-man Study in Lung Perfusion Imaging with the New CZT SPECT Camera (VERITON®)
    Enilorac, B.
    Bouthiba, D.
    Aide, N.
    Nganoa, C.
    Roth, N.
    Agostini, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S154 - S154
12345